OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. A variety of strategies are employed enhance antibody titer, comprising process parameter optimization, cell line development, and the use of perfusion technologies. Fine-tuning media composition pla